Evidence map›Paper›PMID 31759225›Full record

ReviewCurrent opinion in chemical biology2020

Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?

Sherri A McFarland, Arkady Mandel, Roger Dumoulin-White, Gilles Gasser

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
29.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 330 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. π-Extended Ru-COUBPY Photosensitizers forJournal of the American Chemical Society · 2025
    Article
  13. Review
  14. Review
  15. Review
  16. RuvidarViruses · 2025
    Article
  17. Advancements and emerging trends in photodynamic therapy: innovations in cancer treatment and beyond.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2025
    Review
  18. Article
  19. Review
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Sherri A McFarlandThe University of Texas at Arlington, Department of Chemistry and Biochemistry, Arlington, TX 76019-0065, USA; The University of North Carolina at Greensboro, Department of Chemistry and Biochemistry, Greensboro, NC 27402-6170, USA. Electronic address: sherri.mcfarland@uta.edu.
Arkady MandelTheralase Technologies Inc., Toronto, Ontario, Canada.
Roger Dumoulin-WhiteTheralase Technologies Inc., Toronto, Ontario, Canada.
Gilles GasserChimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, F-75005 Paris, France. Electronic address: gilles.gasser@chimieparistech.psl.eu.
Centre National de la Recherche Scientifique · FRUniversity of North Carolina at Greensboro · US

Funding

Immunomodulating Ruthenium Metal Complexes for Melanoma PhotodynamicTherapyR01CA222227 · NCI · UNIVERSITY OF TEXAS ARLINGTON · PI GUJAR, SHASHI, MCFARLAND, SHERRI · 2018 to 2022
$2.6M
NCI NIH HHS R01 CA222227
6 · The paper itself

Abstract

Photodynamic therapy (PDT) is an approved medical technique to treat certain forms of cancer. It has been used to complement traditional anticancer modalities such as surgery, chemotherapy or radiotherapy, and in certain cases, to replace these treatments. One critical parameter of PDT is the photosensitizer (PS); historically, a purely organic macrocyclic tetrapyrrole-based structure. This short review surveys two recent clinical examples of metal complexes, namely TOOKAD®-Soluble and TLD-1433, which have ideal photophysical properties to act as PDT PSs. We highlight the important role played by the metal ions in the PS for PDT activity.

Indexed as

Antineoplastic AgentsBacteriochlorophyllsCombined Modality TherapyCoordination ComplexesDrug Screening Assays, AntitumorHumansNeoplasmsPhotochemotherapyPhotosensitizing AgentsSolubilityStructure-Activity RelationshipAntineoplastic AgentsBacteriochlorophyllsCoordination Complexespalladium-bacteriopheophorbidePhotosensitizing AgentsBioinorganic chemistryMedicinal inorganic chemistryMetals in medicinePhotodynamic therapyPhotosensitizer

Identifiers

PMID31759225
PMCPMC7237330
OpenAlexW2989630868

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.